MedPath

Hyteroscopy in abnormal uterine bleeding pateints

Not Applicable
Conditions
Health Condition 1: N719- Inflammatory disease of uterus, unspecified
Registration Number
CTRI/2023/05/052786
Lead Sponsor
Dr Jyoti Ahlawat
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Intermenstrual heavy bleeding (Menometrorrhagia),

2. Frequent cycles (Polymenorrhea), Infrequent menstrual bleeding (Oligomenorrhea).

3. Frequent and heavy menstrual bleeding (Polymenorrhagia),

4. Fibroid uterus

5. Uterovaginal congenital anomaly

Exclusion Criteria

1. IUCD (Intrauterine contraceptive devices),

2. Hormone producing Ovarian tumours in USG,

3. Endocrine disorders like hyperthyroidism- or hypothyroidism,

4. Cervical malignancy

5. on medications like steroids, neuroleptics and anticoagulants,

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
to assess different causes of abnormal uterine bleedingTimepoint: 4 weeks
Secondary Outcome Measures
NameTimeMethod
to correlate hysteroscopic findings with histopathological resultsTimepoint: 8 weeks
© Copyright 2025. All Rights Reserved by MedPath